On August 31, 2024, Pfizer Inc. Executive Vice President Aamir Malik completed a sale of 20,195 shares of the company's common stock. The transaction was executed at a price of $29.01 per share, resulting in a total sale value of approximately $585,857. Following the sale, Malik's direct holdings in Pfizer common stock amounted to 29,548 shares. The sale was reported as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.

On August 31, 2024, Pfizer Inc. Executive Vice President Aamir Malik completed a sale of 20,195 shares of the company's common stock. The transaction was executed at a price of $29.01 per share, resulting in a total sale value of approximately $585,857. Following the sale, Malik's direct holdings in Pfizer common stock amounted to 29,548 shares. The sale was reported as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.